Standout Papers

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer 2007 2026 2013 2019 5.4k
  1. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer (2011)
    Thierry Conroy, Françoise Desseigne et al. New England Journal of Medicine
  2. Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102 (2007)
    Laurent Bedenne, Pierre Michel et al. Journal of Clinical Oncology
  3. Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 (2010)
    Jean‐Pierre Gérard, D. Azria et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 14 from Science/Nature 85 standout
Sub-graph 1 of 18

Citing Papers

Pancreatic cancer
2025 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
74 intermediate papers

Works of Thierry Conroy being referenced

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study
2005
and 5 more

Author Peers

Author Last Decade Papers Cites
Thierry Conroy 7723 3637 3681 81 10.0k
Y. Bécouarn 6868 2261 2169 84 7.9k
Rosine Guimbaud 7517 2226 2452 177 9.3k
Catherine Delbaldo 6186 1552 2673 48 8.0k
Christelle de la Fouchardière 7592 2529 2726 188 10.4k
Françoise Desseigne 6475 1574 1968 76 7.6k
Helmut Oettle 6333 2263 2144 146 8.1k
S. Gourgou-Bourgade 6400 2201 2094 40 7.5k
Gauri R. Varadhachary 7757 3088 3463 196 9.2k
Peter C. Enzinger 4125 3301 3380 145 8.2k
F. Andrew Dorr 4707 1332 2540 47 7.8k

All Works

Loading papers...

Rankless by CCL
2026